Abstract
In this article we review studies in which Automated Neuropsychological Assessment Metrics (ANAM) measures were used to screen for impairment in various clinical populations. These clinical groups include patients with multiple sclerosis, systemic lupus erythematosus, Parkinson's disease, Alzheimer's dementia, acquired brain injury, and migraine headache. Data are also presented from a group of outpatient referrals unselected with respect to clinical condition. Findings support the use of ANAM as a screening procedure for identifying the impaired patient.
MeSH terms
-
Brain Injuries / diagnosis
-
Brain Injuries / psychology
-
Cognition Disorders / diagnosis*
-
Cognition Disorders / psychology
-
Diagnosis, Computer-Assisted / statistics & numerical data*
-
Humans
-
Lupus Erythematosus, Systemic / diagnosis
-
Lupus Erythematosus, Systemic / psychology
-
Mass Screening / statistics & numerical data
-
Migraine Disorders / diagnosis
-
Migraine Disorders / psychology
-
Multiple Sclerosis / diagnosis
-
Multiple Sclerosis / psychology
-
Neuropsychological Tests / statistics & numerical data*
-
Parkinson Disease / diagnosis
-
Parkinson Disease / psychology
-
Psychometrics / statistics & numerical data
-
Reproducibility of Results
-
Risk Factors
-
Software / statistics & numerical data*